TrendingIndustry
AI-Discovered Drug Compounds Enter Phase II Clinical Trials
Three AI-designed molecules show promising results in early human studies
AI Summary
Three drug candidates — two oncology and one rare disease — designed using transformer-based protein structure prediction entered Phase II trials. Results due in 18 months.
Content is being processed…